The TNFalpha gene relates to clinical phenotype in alpha-1-antitrypsin deficiency

Respiratory Research

Volumn 9, Issue , 2008, Pages

  Wood, Alice M ^a   Simmonds, Matthew J ^a   Bayley, Darren L ^b   Newby, Paul R ^a   Gough, Stephen C ^a   Stockley, Robert A ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; SERPINA1 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BLOOD; CASE CONTROL STUDY; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; BRONCHITIS, CHRONIC; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 52649167915     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-9-52     Document Type: Article

References (50)

1. ATS Cigarette smoking and health. Am J Respir Crit Care Med 1996, 153(2):861-865. ATS.
2. Lewitter FI, Tager IB, McGue M, Tishler PV, Speizer FE. Genetic and environmental determinants of level of pulmonary function. Am J Epidemiol 1984, 120(4):518-530.
3. Kueppers F, Miller RD, Gordon H, Hepper NG, Offord K. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am J Med 1977, 63(3):336-342. 10.1016/0002-9343(77)90270-4, 302643.
4. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977, 1(6077):1645-1648. 1607732, 871704.
5. Stockley RA. Neutrophils and protease/antiprotease imbalance. Am J Respir Crit Care Med 1999, 160(5 Pt 2):S49-52.
6. MacNee W. Oxidants/antioxidants and COPD. Chest 2000, 117(5 Suppl 1):303S-17S.
7. Sevenoaks MJ, Stockley RA. Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype?. Respir Res 2006, 7:70. 1479815, 16669999, 10.1186/1465-9921-7-70.
8. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996, 153(2):530-534.
9. Mueller R, Chanez P, Campbell AM, Bousquet J, Heusser C, Bullock GR. Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis. Respir Med 1996, 90(2):79-85. 10.1016/S0954-6111(96)90202-4, 8730325.
10. Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994, 150(5 Pt 1):1453-1455.
11. Sakao S, Tatsumi K, Igari H, Shino Y, Shirasawa H, Kuriyama T. Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 163(2):420-422.
12. Sakao S, Tatsumi K, Igari H, Watanabe R, Shino Y, Shirasawa H, Kuriyama T. Association of tumor necrosis factor-alpha gene promoter polymorphism with low attenuation areas on high-resolution CT in patients with COPD. Chest 2002, 122(2):416-420. 10.1378/chest.122.2.416, 12171811.
13. Hersh CP, Demeo DL, Lange C, Litonjua AA, Reilly JJ, Kwiatkowski D, Laird N, Sylvia JS, Sparrow D, Speizer FE, Weiss ST, Silverman EK. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 2005, 33(1):71-78. 10.1165/rcmb.2005-0073OC, 15817713.
14. Huang SL, Su CH, Chang SC. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 1997, 156(5):1436-1439.
15. Needham M, Stockley RA. Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history. Thorax 2004, 59(5):441-445. 1746985, 15115878, 10.1136/thx.2003.006510.
16. Rodriguez F, de la Roza C, Jardi R, Schaper M, Vidal R, Miravitlles M. Glutathione S-transferase P1 and lung function in patients with alpha1-antitrypsin deficiency and COPD. Chest 2005, 127(5):1537-1543. 10.1378/chest.127.5.1537, 15888825.
17. Silverman EK, Province MA, Campbell EJ, Pierce JA, Rao DC. Variability of pulmonary function in alpha-1-antitrypsin deficiency: residual family resemblance beyond the effect of the Pi locus. Hum Hered 1990, 40(6):340-355.
18. Demeo DL, Campbell EJ, Barker AF, Brantly ML, Eden E, McElvaney NG, Rennard SI, Sandhaus RA, Stocks JM, Stoller JK, Strange C, Turino G, Silverman EK. IL10 Polymorphisms are Associated with Airflow Obstruction in Severe alpha 1-antitrypsin Deficiency. Am J Respir Cell Mol Biol 2007,
19. Novoradovsky A, Brantly ML, Waclawiw MA, Chaudhary PP, Ihara H, Qi L, Eissa NT, Barnes PM, Gabriele KM, Ehrmantraut ME, Rogliani P, Moss J. Endothelial nitric oxide synthase as a potential susceptibility gene in the pathogenesis of emphysema in alpha1-antitrypsin deficiency. American journal of respiratory cell and molecular biology 1999, 20(3):441-447.
20. Hill AT, Campbell EJ, Bayley DL, Hill SL, Stockley RA. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med 1999, 160(6):1968-1975.
21. Churg A, Wang X, Wang RD, Meixner SC, Pryzdial EL, Wright JL. {alpha}-1-Antitrypsin Suppresses TNF{alpha} and MMP-12 Production by Cigarette Smoke-Stimulated Macrophages. Am J Respir Cell Mol Biol 2007,
22. Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis. Lancet 1965, 1(7389):775-779.
23. Dowson LJ, Guest PJ, Hill SL, Holder RL, Stockley RA. High-resolution computed tomography scanning in alpha1-antitrypsin deficiency: relationship to lung function and health status. Eur Respir J 2001, 17(6):1097-1104. 10.1183/09031936.01.00056501, 11491150.
24. Naidich DP, McCauley DI, Khouri NF, Stitik FP, Siegelman SS. Computed tomography of bronchiectasis. Journal of computer assisted tomography 1982, 6(3):437-444. 10.1097/00004728-198206000-00001, 7096687.
25. Muller NL, Staples CA, Miller RR, Abboud RT. "Density mask". An objective method to quantitate emphysema using computed tomography. Chest 1988, 94(4):782-787. 10.1378/chest.94.4.782, 3168574.
26. Holme J, Stockley RA. Radiologic and clinical features of COPD patients with discordant pulmonary physiology: lessons from alpha1-antitrypsin deficiency. Chest 2007, 132(3):909-915. 10.1378/chest.07-0341, 17573491.
27. Soejima K, Yamaguchi K, Kohda E, Takeshita K, Ito Y, Mastubara H, Oguma T, Inoue T, Okubo Y, Amakawa K, Tateno H, Shiomi T. Longitudinal follow-up study of smoking-induced lung density changes by high-resolution computed tomography. American journal of respiratory and critical care medicine 2000, 161(4 Pt 1):1264-1273. 10764322.
28. Simmonds MJ, Heward JM, Howson JM, Foxall H, Nithiyananthan R, Franklyn JA, Gough SC. A systematic approach to the assessment of known TNF-alpha polymorphisms in Graves' disease. Genes Immun 2004, 5(4):267-273. 10.1038/sj.gene.6364066, 15057268.
29. Newby PR, Roberts-Davies EL, Brand OJ, Heward JM, Franklyn JA, Gough SC, Simmonds MJ. Tag SNP screening of the PDCD1 gene for association with Graves' disease. Clinical endocrinology 2007, 67(1):125-128. 10.1111/j.1365-2265.2007.02848.x, 17490403.
30. Sapey E, Bayley D, Ahmad A, Newbold P, Snell N, Stockley RA. Inter-relationships between inflammatory markers in stable COPD patients with bronchitis: the intra and inter patient variability. Thorax 2007,
31. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (Oxford, England) 2005, 21(2):263-265. 10.1093/bioinformatics/bth457, 15297300.
32. Silverman EK, Mosley JD, Rao DC, Palmer LJ, Province MA, Elston RC, Weiss ST, Campbell EJ. Linkage analysis of alpha 1-antitrypsin deficiency: lessons for complex diseases. Hum Hered 2001, 52(4):223-232. 10.1159/000053380, 11713419.
33. Baranova H, Perriot J, Albuisson E, Ivaschenko T, Baranov VS, Hemery B, Mouraire P, Riol N, Malet P. Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis. Hum Genet 1997, 99(6):822-826. 10.1007/s004390050455, 9187680.
34. Management of chronic obstructive pulmonary disease in adults in primary and secondary care . , http://www.nice.org.uk/pdf/CG012_nicceguideline.pdf
35. Parr DG, Guest PG, Reynolds JH, Dowson LJ, Stockley RA. Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 2007, 176(12):1215-1221. 10.1164/rccm.200703-489OC, 17872489.
36. Rennard SI, Fogarty C, Kelsen S, Long W, Ramsdell J, Allison J, Mahler D, Saadeh C, Siler T, Snell P, Korenblat P, Smith W, Kaye M, Mandel M, Andrews C, Prabhu R, Donohue JF, Watt R, Lo KH, Schlenker-Herceg R, Barnathan ES, Murray J. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007, 175(9):926-934. 10.1164/rccm.200607-995OC, 17290043.
37. Seitz M, Wirthmuller U, Moller B, Villiger PM. The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients. Rheumatology (Oxford, England) 2007, 46(1):93-96. 10.1093/rheumatology/kel175, 16720636.
38. Holme J, Stockley JA, Stockley RA. When should we start monitoring alpha 1 antitrypsin deficient subjects?: London. 2007, 62:A140.
39. Wright JL, Farmer SG, Churg A. Synthetic serine elastase inhibitor reduces cigarette smoke-induced emphysema in guinea pigs. Am J Respir Crit Care Med 2002, 166(7):954-960. 10.1164/rccm.200202-098OC, 12359653.
40. Howard TD, Koppelman GH, Xu J, Zheng SL, Postma DS, Meyers DA, Bleecker ER. Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am J Hum Genet 2002, 70(1):230-236. 384891, 11709756, 10.1086/338242.
41. Bayley JP, de Rooij H, van den Elsen PJ, Huizinga TW, Verweij CL. Functional analysis of linker-scan mutants spanning the -376, -308, -244, and -238 polymorphic sites of the TNF-alpha promoter. Cytokine 2001, 14(6):316-323. 10.1006/cyto.2001.0902, 11497492.
42. Rahman P, Siannis F, Butt C, Farewell V, Peddle L, Pellett F, Gladman D. TNFalpha polymorphisms and risk of psoriatic arthritis. Annals of the rheumatic diseases 2006, 65(7):919-923. 10.1136/ard.2005.039164, 16284098.
43. Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, Galle PR, Maerker-Hermann E, Hoehler T. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. The Journal of investigative dermatology 2000, 114(6):1180-1183. 10.1046/j.1523-1747.2000.00001.x, 10844563.
44. Demeo DL, Campbell EJ, Barker AF, Brantly ML, Eden E, McElvaney NG, Rennard SI, Sandhaus RA, Stocks JM, Stoller JK, Strange C, Turino G, Silverman EK. IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency. Am J Respir Cell Mol Biol 2008, 38(1):114-120. 10.1165/rcmb.2007-0107OC, 17690329.
45. Vernooy JH, Kucukaycan M, Jacobs JA, Chavannes NH, Buurman WA, Dentener MA, Wouters EF. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med 2002, 166(9):1218-1224. 10.1164/rccm.2202023, 12403691.
46. Sethi S, Maloney J, Grove L, Wrona C, Berenson CS. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 173(9):991-998. 10.1164/rccm.200509-1525OC, 16474030.
47. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993, 177(2):557-560. 2190902, 8426126, 10.1084/jem.177.2.557.
48. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003, 361(9360):865-872. 10.1016/S0140-6736(03)12715-8, 12642066.
49. Wood AM, Stockley RA. Phenotypic characteristics of alpha 1 antitrypsin deficient sibling pairs show discordance: Toronto. 2008, 176:A418.
50. WTCCC Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447(7145):661-678. 10.1038/nature05911, 17554300, WTCCC.